NCT01767233

Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis

Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis: a Prospective Randomized Controlled Multicenter Study

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 80 (estimated)
• Sponsor: University of Oulu · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Since the majority of patients with necrotizing pancreatitis will experience a leak from the pancreatic duct during their course of disease resulting in intra- and peripancreatic fluid collections, it is reasonable to hypothesize that placement of a ductal stent may prevent some of the late complications and morbidity associated with pancreatic necrosis. This prospective, randomized, controlled multicenter trial investigates the role of early prophylactic ductal stenting in acute necrotizing pancreatitis. The purpose of the study is to determinate the safety and feasibility of early prophylactic pancreatic duct stenting in necrotizing pancreatitis in reducing complications, length of stay in hospital and in in-tensive care unit compared to the traditional treatment.

Conditions

• Acute Necrotizing Pancreatitis

Interventions

Type	Name	Description
PROCEDURE	ERCP and pancreatic stenting

Timeline

• Start date: 2011-01-01
• Primary completion: 2014-12-01
• Completion: 2015-12-01
• First posted: 2013-01-14
• Last updated: 2013-01-14

Locations

1 site across 1 country: Finland